Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the net profit margin high or low?
The net profit margin of 17.16% is in line with its 5-year average of 17.00%, around the middle of its 5-year range (13.25%–21.81%).
As of the fiscal period ended Tuesday, June 30, 2026. 0.26% above its 12-month average of 17.11%.
Reported quarterly profit margin; no daily interpolation.
NET PROFIT MARGIN
17.16%
NET PROFIT MARGIN AVG TTM
17.11%
NET PROFIT MARGIN AVG 3Y
17.39%
NET PROFIT MARGIN AVG 5Y
16.76%
NET PROFIT MARGIN AVG 10Y
14.21%
NET PROFIT MARGIN AVG 15Y
N/A
NET PROFIT MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
+0.26%
CURRENT VS 3Y AVG
-1.33%
CURRENT VS 5Y AVG
+2.36%
CURRENT VS 10Y AVG
+20.72%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
9.05%
median of 79 covered companies
CURRENT VS SECTOR MEDIAN
+89.59%
vs the sector median at left
Medpace Holdings, Inc.
Market Cap
$16.11B
Net Profit Margin
17.16%
TTM Avg
17.11%
3Y Avg
17.39%
5Y Avg
16.76%
Market Cap
$16.97B
Net Profit Margin
13.18%
TTM Avg
16.70%
3Y Avg
17.87%
5Y Avg
22.37%
Market Cap
$14.80B
Net Profit Margin
17.33%
TTM Avg
12.25%
3Y Avg
14.36%
5Y Avg
15.15%
Market Cap
$14.10B
Net Profit Margin
5.57%
TTM Avg
9.62%
3Y Avg
9.77%
5Y Avg
24.94%
Market Cap
$18.17B
Net Profit Margin
9.05%
TTM Avg
10.17%
3Y Avg
9.38%
5Y Avg
6.86%
Market Cap
$13.52B
Net Profit Margin
-9.27%
TTM Avg
-7.30%
3Y Avg
-3.29%
5Y Avg
1.14%
Market Cap
$12.11B
Net Profit Margin
9.99%
TTM Avg
10.36%
3Y Avg
10.48%
5Y Avg
22.21%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Medpace Holdings, Inc. (MEDP) | $16.11B | 17.16% | 17.11% | 17.39% | 16.76% |
| DaVita Inc. (DVA)vs › | $15.41B | 5.65% | 6.39% | 5.83% | 6.41% |
| Hologic, Inc. (HOLX)vs › | $16.97B | 13.18% | 16.70% | 17.87% | 22.37% |
| Solventum Corporation (SOLV)vs › | $14.80B | 17.33% | 12.25% | 14.36% | 15.15% |
| The Cooper Companies, Inc. (COO)vs › | $14.10B | 5.57% | 9.62% | 9.77% | 24.94% |
| Zimmer Biomet Holdings, Inc. (ZBH)vs › | $18.17B | 9.05% | 10.17% | 9.38% | 6.86% |
| Baxter International Inc. (BAX)vs › | $13.52B | -9.27% | -7.30% | -3.29% | 1.14% |
| Revvity, Inc. (RVTY)vs › | $12.55B | 8.30% | 9.60% | 8.02% | 12.66% |
| Align Technology, Inc. (ALGN)vs › | $12.11B | 9.99% | 10.36% | 10.48% | 22.21% |
| Viatris Inc. (VTRS)vs › | $20.45B | -2.04% | -14.44% | -3.94% | -4.74% |
Operating Margin
21.0%
Net Profit Margin
17.2%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | 17.16% |
| 2026-03-31 | 17.53% |
| 2025-12-31 | 19.07% |
| 2025-09-30 | 16.84% |
| 2025-06-30 | 14.96% |
| 2025-03-31 | 20.52% |
| 2024-12-31 | 21.81% |
| 2024-09-30 | 18.08% |
| 2024-06-30 | 16.73% |
| 2024-03-31 | 20.07% |
| 2023-12-31 | 15.71% |
| 2023-09-30 | 14.32% |
| 2023-06-30 | 13.25% |
| 2023-03-31 | 16.79% |
| 2022-12-31 | 17.42% |
| 2022-09-30 | 17.21% |
| 2022-06-30 | 14.05% |
| 2022-03-31 | 18.53% |
| 2021-12-31 | 16.22% |
| 2021-09-30 | 16.43% |
| 2021-06-30 | 14.35% |
| 2021-03-31 | 16.66% |
| 2020-12-31 | 19.59% |
| 2020-09-30 | 18.00% |
| 2020-06-30 | 11.76% |
| 2020-03-31 | 12.54% |
| 2019-12-31 | 12.97% |
| 2019-09-30 | 11.09% |
| 2019-06-30 | 12.82% |
| 2019-03-31 | 9.56% |
| 2018-12-31 | 11.85% |
| 2018-09-30 | 10.77% |
| 2018-06-30 | 9.74% |
| 2018-03-31 | 8.92% |
| 2017-12-31 | 10.02% |
| 2017-09-30 | 8.89% |
| 2017-06-30 | 8.99% |
| 2017-03-31 | 7.92% |
| 2016-12-31 | -0.02% |
| 2016-09-30 | 4.67% |
| 2016-06-30 | 4.68% |
| 2016-03-31 | 3.46% |
| 2015-12-31 | -8.93% |
| 2015-09-30 | -0.14% |
| 2015-06-30 | 0.11% |
| 2015-03-31 | -0.07% |
| 2014-03-31 | -1.59% |
